Genomic targets of nuclear estrogen receptors

Molecular Endocrinology

Volumn 18, Issue 8, 2004, Pages 1859-1875

  O'Lone, Raegan ^a   Frith, Martin C ^a,c,d   Karlsson, Elinor K ^a   Hansen, Ulla ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b Boston University   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BLOOD CLOTTING FACTOR 12; CALBINDIN; CATHEPSIN D; COMPLEMENT COMPONENT C3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; ENDOTHELIAL CELL GROWTH FACTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; LACTOFERRIN; LIPOCALIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OSTEOPONTIN; OXYTOCIN; OXYTOCIN RECEPTOR; PALINDROMIC DNA; PROGESTERONE RECEPTOR; PROLACTIN; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN C JUN; PROTHYMOSIN ALPHA; SCATTER FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR ALPHA; UTEROGLOBIN; VASCULOTROPIN;

ALGORITHM; AMINO ACID SEQUENCE; BINDING AFFINITY; BINDING SITE; BREAST CANCER; CALCULATION; CANCER CELL; CELL FUNCTION; CELL TYPE; DNA BINDING; DNA FLANKING REGION; DNA SEQUENCE; DNA TRANSFECTION; ESTROGEN RESPONSIVE ELEMENT; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INSERTION; GENE MUTATION; GENE TARGETING; GENETIC VARIABILITY; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; IMMUNOPRECIPITATION; LIVER CELL; NONHUMAN; ONCOGENE C FOS; PHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REGULATORY DNA SEQUENCE; REPORTER GENE; SAMPLE SIZE; SEQUENCE ANALYSIS; SHORT SURVEY; STATISTICAL SIGNIFICANCE; TISSUE SPECIFICITY;

ANIMALS; BASE SEQUENCE; CELL NUCLEUS; ESTROGENS; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS;

INSERTION SEQUENCES; MAMMALIA;

EID: 3543119043     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0044     Document Type: Short Survey

References (118)

1. Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PGV, Montano M, Sun J, Weis K, Katzenellenbogen JA 2000 Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 74:279-285
2. Fliss AE, Benzeno S, Rao J, Caplan AJ 2000 Control of estrogen receptor ligand binding by Hsp90. J Steroid Biochem Mol Biol 72:223-230
3. Jakacka M, Ito M, Weiss J, Chien P-Y, Gehm BD, Jameson JL 2001 Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276:13615-13621
4. Sanchez R, Nguyen D, Rocha W, White JH, Mader S 2002 Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 24:244-254
5. Klinge CM 2000 Estrogen receptor interaction with co-activators and co-repressors. Steroids 65:227-251
6. Moggs JG, Orphanides G 2001 Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep 2:775-781
7. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
8. Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson J-Å 2001 Mechanisms of estrogen action. Physiol Rev 81:1535-1565
9. Glass CK, Rosenfeld MG 2000 The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141
10. Nadal A, Ropero AB, Fuentes E, Soria B 2001 The plasma membrane estrogen receptor: nuclear or unclear? Trends Pharmacol Sci 22:597-599
11. Wong C-W, McNally C, Nickbarg E, Komm BS, Cheskis BJ 2002 Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99:14783-14788
12. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298:843-846
13. Björnström L, Sjöberg M 2002 Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol 16:2202-2214
14. Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC 2003 Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651-1664
15. McDonnell DP, Norris JD 2002 Connections and regulation of the human estrogen receptor. Science 296:1642-1644
16. Levin ER 2002 Cellular functions of plasma membrane estrogen receptors. Steroids 67:471-475
17. Saunders PTK 1998 Oestrogen receptor β (ERb). Rev Reprod 3:164-171
18. Pettersson K, Grandien K, Kuiper GGJM, Gustafsson J-Å 1997 Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol Endocrinol 11:1486-1496
19. Cowley SM, Hoare S, Mosselman S, Parker MG 1997 Estrogen receptors a and b form heterodimers on DNA. J Biol Chem 272:19858-19862
20. Stein B, Yang MX 1995 Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBP b. Mol Cell Biol 15:4971-4979
21. Galien R, Garcia T 1997 Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site. Nucleic Acids Res 25:2424-2429
22. Ray A, Prefontaine KE, Ray P 1994 Down-modulation of interleukin-6 gene expression by 17 β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 269:12940-12946
23. Boffelli D, Zajchowski DA, Yang Z, Lawn RM 1999 Estrogen modulation of apolipoprotein(a) expression. Identification of a regulatory element. J Biol Chem 274:15569-15574
24. Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K, Morishige K, Ohmichi M, Matsuzawa Y, Murata Y 2000 Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J Biol Chem 275:11404-11411
25. Schmitt M, Bausero P, Simoni P, Queuche D, Geoffroy V, Marschal C, Kempf J, Quirin-Stricker C 1995 Positive and negative effects of nuclear receptors on transcription activation by AP-1 of the human choline acetyltransferase proximal promoter. J Neurosci Res 40:152-164
26. Coleman KM, Smith CL 2001 Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci 6:D1379-D1391
27. Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C, Lisanti MP, Katzenellenbogen BS, Kato S, Hopp T, Fuqua SAW, Lopez GN, Kushner PJ, Pestell RG 2001 Direct acetylation of the estrogen receptor a hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 276:18375-18383
28. Wells L, Vosseller K, Hart GW 2001 Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 291:2376-2378
29. Lannigan DA 2003 Estrogen receptor phosphorylation. Steroids 68:1-9
30. McKenna NJ, O'Malley BW 2002 Minireview: nuclear receptor coactivators - an update. Endocrinology 143:2461-2465
31. McKenna NJ, O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474
32. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919
33. Bodine PVN, Green J, Harris HA, Bhat RA, Stein GS, Lian JB, Komm BS 1997 Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line. J Cell Biochem 65:368-387
34. Mendelsohn ME 2002 Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 90:3F-6F
35. Villablanca AC, Lewis KA, Rutledge JC 2002 Time- and dose-dependent differential upregulation of three genes by 17β-estradiol in endothelial cells. J Appl Physiol 92:1064-1073
36. Li C, Briggs MR, Ahlborn TE, Kraemer FB, Liu J 2001 Requirement of Sp1 and estrogen receptor a interaction in 17β-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology 142:1546-1553
37. Kato S, Tora L, Yamauchi J, Masushige S, Bellard M, Chambon P 1992 A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically. Cell 68:731-742
38. Vanacker J-M, Pettersson K, Gustafsson J-Å, Laudet V 1999 Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER)α, but not by ERβ. EMBO J 18:4270-4279
39. Klein-Hitpass L, Schorpp M, Wagner U, Ryffel GU 1986 An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46:1053-1061
40. Wood JR, Likhite VS, Loven MA, Nardulli AM 2001 Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol Endocrinol 15:1114-1126
41. Yi P, Driscoll MD, Huang J, Bhagat S, Hilf R, Bambara RA, Muyan M 2002 The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ERα and ERβ. Mol Endocrinol 16:674-693
42. Wood JR, Greene GL, Nardulli AM 1998 Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol 18:1927-1934
43. Klinge CM, Jernigan SC, Smith SL, Tyulmenkov W, Kulakosky PC 2001 Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor α(1). Mol Cell Endocrinol 174:151-166
44. Hall JM, McDonnell DP, Korach KS 2002 Allosteric regulation of estrogen receptor structure, function, and coactivatory recruitment by different estrogen response elements. Mol Endocrinol 16:469-486
45. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS 1997 Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510
46. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
47. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, Mclnerney E, Katzenellenbogen BS, Enmark E, Gustafsson J-Å, Nilsson S, Kushner PJ 1999 The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 13:1672-1685
48. Li X-M, Onishi Y, Kuwabara K, Rho J, Wada-Kiyama Y, Sakuma Y, Kiyama R 2002 Ligand-dependent transcriptional enhancement by DNA curvature between two half motifs of the estrogen response element in the human estrogen receptor α gene. Gene 294:279-290
49. Stormo GD 2000 DNA binding sites: representation and discovery. Bioinformatics 16:16-23
50. Lawrence CE, Altschul SF, Boguski MS, Liu JS, Neuwald AF, Wootton JC 1993 Detecting subtle sequence signals: a Gibbs sampling strategy for multiple alignment. Science 262:208-214
51. Liu JS, Neuwald AF, Lawrence CE 1995 Bayesian models for multiple local sequence alignment and Gibbs sampling strategies. J Am Stat Assoc 90:1156-1170
52. Frith MC, Fu Y, Yu L, Chen J-F, Hansen U, Weng Z 2004 Detection of functional DNA motifs via statistical overrepresentation. Nucleic Acids Res 32:1372-1381
53. Aranda A, Pascual A 2001 Nuclear hormone receptors and gene expression. Physiol Rev 81:1269-1304
54. Martini PGV, Katzenellenbogen BS 2001 Regulation of prothymosin α gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs. Endocrinology 142:3493-3501
55. Treilleux I, Peloux N, Brown M, Sergeant A 1997 Human estrogen receptor (ER) gene promoter-P1: estradiol-independent activity and estradiol inducibility in ER+ and ER- cells. Mol Endocrinol 11:1319-1331
56. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D 2002 The human genome browser at UCSC. Genome Res 12:996-1006
57. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, et al. 2002 Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562
58. Dermitzakis ET, Clark AG 2002 Evolution of transcription factor binding sites in mammalian gene regulatory regions: conservation and turnover. Mol Biol Evol 19:1114-1121
59. Ludwig MZ, Bergman C, Patel NH, Kreitman M 2000 Evidence for stabilizing selection in a eukaryotic enhancer element. Nature 403:564-567
60. Yuh C-H, Brown CT, Livi CB, Rowen L, Clarke PJC, Davidson EH 2002 Patchy interspecific sequence similarities efficiently identify positive cis-regulatory elements in the sea urchin. Dev Biol 246:148-161
61. Day RN, Koike S, Sakai M, Muramatsu M, Maurer RA 1990 Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol 4:1964-1971
62. Xing W, Archer TK 1998 Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. Mol Endocrinol 12:1310-1321
63. Aerts S, Thijs G, Coessens B, Staes M, Moreau Y, De Moor B 2003 Toucan: deciphering the cis-regulatory logic of coregulated genes. Nucleic Acids Res 31:1753-1764
64. Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y 2003 Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 13:773-780
65. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E 2003 MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 31:3576-3579
66. Frith MC, Li MC, Weng Z 2003 Cluster-Buster: finding dense clusters of motifs in DNA sequences. Nucleic Acids Res 31:3666-3668
67. Watanabe T, Inoue S, Hiroi H, Orimo A, Kawashima H, Muramatsu M 1998 Isolation of estrogen-responsive genes with a CpG island library. Mol Cell Biol 18:442-449
68. Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S 2000 Promoter analysis and chromosomal mapping of human EBAG9 gene. Biochem Biophys Res Commun 273:654-660
69. Ikeda K, Orimo A, Higashi Y, Muramatsu M, Inoue S 2000 Efp as a primary estrogen-responsive gene in human breast cancer. FEBS Lett 472:9-13
70. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M 1999 Estrogen activates telomerase. Cancer Res 59:5917-5921
71. Berry M, Nunez A-M, Chambon P 1989 Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86:1218-1222
72. Zhang Z, Teng CT 2000 Estrogen receptor-related receptor a1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J Biol Chem 275:20837-20846
73. Choi I, Gudas LJ, Katzenellenbogen BS 2000 Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region. Mol Cell Endocrinol 164:225-237
74. Richard S, Zingg HH 1990 The human oxytocin gene promoter is regulated by estrogens. J Biol Chem 265:6098-6103
75. Citarella F, Misiti S, Felici A, Farsetti A, Pontecorvi A, Fantoni A 1996 Estrogen induction and contact phase activation of human factor XII. Steroids 61:270-276
76. Norris JD, Fan D, Wagner BL, McDonnell DP 1996 Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol 10:1605-1616
77. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A 1999 Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 33:108-115
78. Seth P, Porter D, Lahti-Domenici J, Geng Y, Richardson A, Polyak K 2002 Cellular and molecular targets of estrogen in normal human breast tissue. Cancer Res 62:4540-4544
79. Wang F, Porter W, Xing W, Archer TK, Safe S 1997 Identification of a functional imperfect estrogen-responsive element in the 5′-promoter region of the human cathepsin D gene. Biochemistry 36:7793-7801
80. Krishnan V, Wang X, Safe S 1994 Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269:15912-15917
81. Cavailles V, Augereau P, Rochefort H 1993 Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci USA 90:203-207
82. Jiang J-G, Bell A, Liu Y, Zarnegar R 1997 Transcriptional regulation of the hepatocyte growth factor gene by the nuclear receptors chicken ovalbumin upstream promoter transcription factor and estrogen receptor. J Biol Chem 272:3928-3934
83. Scholz A, Truss M, Beato M 1998 Hormone-induced recruitment of Sp1 mediates estrogen activation of the rabbit uteroglobin gene in endometrial epithelium. J Biol Chem 273:4360-4366
84. 9k gene. Complete structure and implications on steroid hormone regulation. J Mol Biol 235:1231-1238
85. L'Horset F, Blin C, Colnot S, Lambert M, Thomasset M, Perret C 1994 Calbindin-D9k gene expression in the uterus: study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element. Endocrinology 134:11-18
86. Bale TL, Dorsa DM 1997 Cloning, novel promoter sequence, and estrogen regulation of a rat oxytocin receptor gene. Endocrinology 138:1151-1158
87. Hyder SM, Nawaz Z, Chiappetta C, Yokoyama K, Stancel GM 1995 The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. J Biol Chem 270:8506-8513
88. El-Ashry D, Chrysogelos SA, Lippman ME, Kern FG 1996 Estrogen induction of TGF-α is mediated by an estrogen response element composed of two imperfect palindromes. J Steroid Biochem Mol Biol 59:261-269
89. Vyhlidal C, Samudio I, Kladde MP, Safe S 2000 Transcriptional activation of transforming growth factor α by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J Mol Endocrinol 24:329-338
90. Mueller MD, Vigne J-L, Minchenko A, Lebovic DI, Leitman DC, Taylor RN 2000 Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc Natl Acad Sci USA 97:10972-10977
91. Di Croce L, Vicent GP, Pecci A, Bruscalupi G, Trentalance A, Beato M 1999 The promoter of the rat 3-hydroxy-3-methylglutaryl coenzyme A reductase gene contains a tissue-specific estrogen-responsive region. Mol Endocrinol 13:1225-1236
92. Scott REM, Wu-Peng XS, Yen PM, Chin WW, Pfaff DW 1997 Interactions of estrogen- and thyroid hormone receptors on a progesterone receptor estrogen response element (ERE) sequence: a comparison with the vitellogenin A2 consensus ERE. Mol Endocrinol 11:1581-1592
93. Kraus WL, Montano MM, Katzenellenbogen BS 1994 Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene. Mol Endocrinol 8:952-969
94. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM 2000 Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60:3183-3190
95. Shupnik MA, Rosenzweig BA 1991 Identification of an estrogen-responsive element in the rat LH β gene. DNA-estrogen receptor interactions and functional analysis. J Biol Chem 266:17084-17091
96. Pethe V, Shekhar PVM 1999 Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene. J Biol Chem 274:30969-30978
97. Watanabe T, Inoue S, Hiroi H, Orimo A, Muramatsu M 1999 NMDA receptor type 2D gene as target for estrogen receptor in the brain. Brain Res Mol Brain Res 63:375-379
98. Rishi AK, Shao Z-M, Baumann RG, Li X-S, Sheikh MS, Kimura S, Bashirelahi N, Fontana JA 1995 Estradiol regulation of the human retinoic acid receptor α gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res 55:4999-5006
99. Petz LN, Nardulli AM 2000 Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol Endocrinol 14:972-985
100. Wang F, Samudio I, Safe S 2001 Transcriptional activation of rat creatine kinase B by 17β-estradiol in MCF-7 cells involves an estrogen responsive element and GC-rich sites. J Cell Biochem 84:156-172
101. Wu-Peng XS, Pugliese TE, Dickerman HW, Pentecost BT 1992 Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene. Mol Endocrinol 6:231-240
102. Xie W, Duan R, Safe S 1999 Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions. Endocrinology 140:219-227
103. Qin C, Singh P, Safe S 1999 Transcriptional activation of insulin-like growth factor-binding protein-4 by 17β-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology 140:2501-2508
104. Porter W, Saville B, Hoivik D, Safe S 1997 Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580
105. Xie W, Duan R, Chen I, Samudio I, Safe S 2000 Transcriptional activation of thymidylate synthase by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinology 141:2439-2449
106. Salvatori L, Ravenna L, Felli MP, Cardillo MR, Russo MA, Frati L, Gulino A, Petrangeli E 2000 Identification of an estrogen-mediated deoxyribonucleic acid-binding independent transactivation pathway on the epidermal growth factor receptor gene promoter. Endocrinology 141:2266-2274
107. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H 2000 The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275:25781-25790
108. Duan R, Porter W, Safe S 1998 Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology 139:1981-1990
109. Schultz JR, Petz LN, Nardulli AM 2003 Estrogen receptor α and Sp1 regulate progesterone receptor gene expression. Mol Cell Endocrinol 201:165-175
110. Stoner M, Wang F, Wormke M, Nguyen T, Samudio I, Vyhlidal C, Marme D, Finkenzeller G, Safe S 2000 Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor α and Sp3 proteins. J Biol Chem 275:22769-22779
111. Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C, Safe S 1999 Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J Biol Chem 274:32099-32107
112. Castro-Rivera E, Samudio I, Safe S 2001 Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem 276:30853-30861
113. Sabbah M, Courilleau D, Mester J, Redeuilh G 1999 Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96:11217-11222
114. Wang W, Dong L, Saville B, Safe S 1999 Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol Endocrinol 13:1373-1387
115. Shang Y, Brown M 2002 Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468
116. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T 1994 Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269:16433-16442
117. Sukovich DA, Mukherjee R, Benfield PA 1994 A novel, cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element. Mol Cell Biol 14:7134-7143
118. Stedronsky K, Telgmann R, Tillmann G, Walther N, Ivell R 2002 The affinity and activity of the multiple hormone response element in the proximal promoter of the human oxytocin gene. J Neuroendocrinol 14:472-485